Medtronic (MDT) Net Cash Flow (2014 - 2026)

Medtronic's Net Cash Flow history runs 13 years deep, the most recent figure standing at -$159.0 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 562.5% year-over-year to -$159.0 million; the TTM figure through Jan 2026 stood at -$428.0 million (down 88.55% YoY), while the FY2025 annual figure was $746.0 million, up 2672.41% from the prior year.
• Net Cash Flow came in at -$159.0 million for Q1 2026 at Medtronic, down from $48.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.8 billion in Q4 2022 to a low of -$2.9 billion in Q2 2023.
• A 5-year average of -$107.5 million and a median of -$4.0 million in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow jumped 3036.84% in 2022 and slumped 25200.0% in 2025, its largest moves.
• Medtronic's Net Cash Flow stood at $2.8 billion in 2022, then tumbled by 94.73% to $147.0 million in 2023, then sank by 46.26% to $79.0 million in 2024, then sank by 39.24% to $48.0 million in 2025, then sank by 431.25% to -$159.0 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$159.0 million, $48.0 million, and -$1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison